Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2002
08/22/2002US20020115810 Anionic polymerization of functionalized styrene derivatives containing carbazole
08/22/2002US20020115806 Olefin polymerization catalyst system is a reaction product of a metallocenes and a cocatalyst containing fluoroaryl substituted secondary amine or phsophine compound and an anion containing group 13 element which is noncoordinatig
08/22/2002US20020115708 Antiestrogenic and antitumorigenic activities
08/22/2002US20020115707 Process for preparing pure ondansetron hydrochloride dihydrate
08/22/2002US20020115692 Prophylaxis or treatment of a disease or disorder in a mammal in which inappropriate leukocyte trafficking plays a role
08/22/2002US20020115671 Inhibitors of p38-a kinase
08/22/2002US20020115670 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
08/22/2002US20020115657 Such as 3-(4-(2-(10,11-dihydro-dibenzo(b,f)azepin-5-yl)-ethoxy)-phenyl)-2 -ethoxypropionic acid; for treatment/ prevention of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
08/22/2002US20020115651 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
08/22/2002US20020115076 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis
08/22/2002DE10108215A1 Pharmazeutische Kombination von Antagonisten von Angiotensin II und Hemmern von Angiotensin II konvertierendem Enzym A pharmaceutical combination of antagonists of angiotensin II inhibitors and angiotensin II converting enzyme
08/22/2002CA2433000A1 Isolation of anthracene and carbazole by melt-crystallization
08/22/2002CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/21/2002EP1232144A2 Novel il-8 receptor antagonists
08/21/2002EP1231916A2 Use of indirubine derivatives for making medicines
08/21/2002EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/21/2002EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
08/21/2002CN1365347A Anthracene derivatives and organic electroleuminescents device made by using the same
08/20/2002US6437141 Cyanine dyes and synthesis methods thereof
08/20/2002US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease
08/20/2002US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives
08/20/2002US6436957 Indole derivatives as 5-HT1 agonists
08/20/2002US6436949 Heterocyclically substituted benzamides and their use
08/20/2002US6436939 Treatment of central nervous system disorders including sleep/wake disorders, dementia, alzheimer's disease, epilepsy, narcolepsy, eating disorders, motion sickness, vertigo
08/20/2002US6436923 Compounds and methods for modulation of estrogen receptors
08/20/2002CA2056364C Compositions and methods of effecting contraception
08/15/2002WO2002062773A1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
08/15/2002WO2002062763A2 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
08/15/2002WO2002062762A2 Potassium channel openers
08/15/2002WO2002062758A1 Indoline derivative and process for producing the same
08/15/2002WO2002062290A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
08/15/2002WO2002042244A3 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
08/15/2002WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/15/2002WO2002032419A3 Methods for modulating bladder function
08/15/2002WO2002018369A3 Peptidomimetic protease inhibitors
08/15/2002WO2001072685B1 Polyamine analogues as cytotoxic agents
08/15/2002US20020111461 Peptidomimetic compound for us ein the treatment of diabetes
08/15/2002US20020111385 Synergistic mixtures
08/15/2002US20020111358 Phenoxypropylamine compounds
08/15/2002US20020111351 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
08/15/2002US20020111344 Antidiabetic agetns, dietetics
08/15/2002US20020111265 Group-15 cationic compounds for olefin polymerization catalysts
08/15/2002CA2437405A1 Potassium channel openers
08/15/2002CA2437134A1 Indoline derivative and process for producing the same
08/14/2002EP1231209A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound
08/14/2002EP1230218A1 Positive modulators of nicotinic receptor agonists
08/14/2002EP1230217A1 Positive modulators of nicotinic receptor agonists
08/14/2002EP1230216A1 Positive modulators of nicotinic receptor agonists
08/14/2002EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
08/14/2002EP1229907A1 Prevention of plaque rupture by acat inhibitors
08/14/2002EP1194375A4 Synthetic porous crystalline mcm-68, its synthesis and use
08/14/2002EP1137739A4 Catalytic cracking process using an mcm-68 catalyst
08/14/2002EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/14/2002EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
08/14/2002EP0722439B1 Hiv protease inhibitors
08/14/2002DE10103208A1 Gewinnung von Anthracen und Carbazol durch Schmelzkristallisation Of anthracene and carbazole by melt crystallization
08/14/2002CN1364158A Mutilin derivatives and their use as antibacterials
08/14/2002CN1364157A N-(indolcarbonyl) piperazin derivatives
08/14/2002CN1364155A N-Cyanomethyl amides as protease inhibitors
08/14/2002CN1089086C Luminide and macroluminide class of pharmaceuticals
08/14/2002CN1089008C In-vivo diagnostic process by near infrared radiation
08/13/2002US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
08/13/2002US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents
08/13/2002US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors
08/13/2002US6432987 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action
08/13/2002US6432962 Antiinflammatory agents
08/13/2002CA2216633C Synthesis of bis-indolylmaleimides
08/08/2002WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
08/08/2002WO2002060867A2 Carbazole derivatives and their uses as heparanase inhibitors
08/08/2002WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity
08/08/2002WO2002060438A1 Substituted indoles and their use as integrin antagonists
08/08/2002WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
08/08/2002WO2002060340A2 Method for identifying maxi-k channel blockers
08/08/2002WO2002060339A2 Ophthalmic compositions for treating ocular hypertension
08/08/2002WO2002018327A3 Guanidinobenzamides as mc4-r agonists
08/08/2002WO2002006189A3 Aniline derivatives
08/08/2002WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors
08/08/2002WO2001056555A3 Use of cox-2 inhibitors for the treatment of constipation
08/08/2002US20020107418 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide
08/08/2002US20020107406 Calcium receptor-active compounds
08/08/2002US20020107405 Such as 9-phenyl-3,6-bis(5(carbazol-3-yl)-thiophen-2-yl)-9H-carbazole; electroluminescence; high glass transition temperature
08/08/2002US20020107404 Sulfur-containing indirubin derivatives, their production and use
08/08/2002US20020107266 Amides used particularly in the treatment, prevention or amelioration of one or more symptoms of malaria or Chagas' disease; inhibiting the activity of falcipain or cruzain
08/08/2002US20020107242 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
08/08/2002US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease
08/08/2002CA2672805A1 Pyrimidine derivatives
08/08/2002CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells
08/08/2002CA2436130A1 Substituted indoles and their use as integrin antagonists
08/08/2002CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
08/08/2002CA2434485A1 Ophthalmic compositions for treating ocular hypertension
08/08/2002CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity
08/07/2002EP1229037A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1229028A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1229027A1 Heterocyclic N-acetonylbenzamides and their use as fungicides
08/07/2002EP1228071A1 Pharmaceutically active isoindoline derivatives
08/07/2002EP1228041A2 Indole derivatives and their use as 5ht2a ligands
08/07/2002EP1228037A1 Compounds having mif antagonist activity
08/07/2002EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
08/07/2002EP1227786A1 Agent for dyeing fibres comprising an indoline/indolium derivative
08/07/2002EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections